Sacituzumab govitecan-hziy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Sacituzumab govitecan-hziy, covering 2021-04-06 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer [Phase 2]